CRIS Current Research Information System

ERCOLANI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.653
AS - Asia 26.349
EU - Europa 19.452
SA - Sud America 1.616
AF - Africa 1.444
Continente sconosciuto - Info sul continente non disponibili 1.376
OC - Oceania 44
Totale 78.934
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.081
SG - Singapore 7.181
VN - Vietnam 6.664
CN - Cina 5.984
IT - Italia 4.715
GB - Regno Unito 3.443
DE - Germania 2.535
HK - Hong Kong 2.044
NL - Olanda 1.930
SE - Svezia 1.675
IN - India 1.555
BR - Brasile 1.178
FR - Francia 1.139
RU - Federazione Russa 871
BD - Bangladesh 706
IE - Irlanda 653
UA - Ucraina 611
KR - Corea 537
JP - Giappone 433
FI - Finlandia 412
ZA - Sudafrica 381
CI - Costa d'Avorio 356
CH - Svizzera 355
CA - Canada 286
TG - Togo 260
EE - Estonia 255
BG - Bulgaria 179
AR - Argentina 171
SC - Seychelles 169
PH - Filippine 164
AT - Austria 147
JO - Giordania 146
ID - Indonesia 142
TH - Thailandia 127
MX - Messico 120
IQ - Iraq 101
NG - Nigeria 100
PL - Polonia 94
TR - Turchia 94
BE - Belgio 83
ES - Italia 81
PK - Pakistan 70
EC - Ecuador 68
TW - Taiwan 50
SA - Arabia Saudita 49
CO - Colombia 46
CL - Cile 44
GR - Grecia 41
MY - Malesia 41
UZ - Uzbekistan 40
AU - Australia 38
IR - Iran 38
JM - Giamaica 34
VE - Venezuela 33
MA - Marocco 32
RO - Romania 31
LT - Lituania 29
PE - Perù 29
HR - Croazia 28
PY - Paraguay 27
CR - Costa Rica 25
LB - Libano 25
AE - Emirati Arabi Uniti 24
EG - Egitto 23
PT - Portogallo 23
HN - Honduras 21
KE - Kenya 20
ET - Etiopia 19
IL - Israele 18
NP - Nepal 18
AL - Albania 15
GH - Ghana 15
TN - Tunisia 15
AZ - Azerbaigian 14
DZ - Algeria 12
UY - Uruguay 12
GT - Guatemala 11
KZ - Kazakistan 11
NI - Nicaragua 11
PR - Porto Rico 11
RS - Serbia 11
PS - Palestinian Territory 10
SV - El Salvador 10
KH - Cambogia 9
MK - Macedonia 9
MU - Mauritius 9
CZ - Repubblica Ceca 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
LU - Lussemburgo 8
MD - Moldavia 8
SK - Slovacchia (Repubblica Slovacca) 8
HU - Ungheria 7
SN - Senegal 7
BA - Bosnia-Erzegovina 6
BS - Bahamas 6
OM - Oman 6
SI - Slovenia 6
TT - Trinidad e Tobago 6
BB - Barbados 5
Totale 77.424
Salva come PNG Salva come JPEG
Città #
Singapore 5.039
Southend 2.958
Ashburn 2.894
Fairfield 2.820
Hong Kong 1.910
Chandler 1.662
San Jose 1.624
Ho Chi Minh City 1.366
Dong Ket 1.321
Woodbridge 1.238
Santa Clara 1.160
Hanoi 1.128
Wilmington 1.111
Hefei 1.053
Seattle 1.011
Houston 975
Cambridge 867
Princeton 785
Council Bluffs 772
Beijing 745
Kerkrade 665
Ann Arbor 652
Los Angeles 645
Boardman 633
Bologna 599
Dublin 599
Frankfurt am Main 520
Lauterbourg 443
Seoul 442
Dallas 419
New York 396
Milan 370
Tokyo 360
Abidjan 356
Munich 339
Eygelshoven 338
Jacksonville 333
Westminster 316
Nanjing 314
Helsinki 305
Padova 264
Lomé 260
Buffalo 259
Delhi 247
Berlin 237
Da Nang 221
Florence 206
Haiphong 204
Bern 201
São Paulo 188
San Diego 178
Jinan 172
Sofia 169
Rome 166
Shenyang 160
Saint Petersburg 149
Guangzhou 145
Amman 141
Redondo Beach 141
Redmond 140
Shanghai 137
Turin 131
Chicago 128
Changsha 116
Menlo Park 112
Bengaluru 108
Nanchang 95
Dearborn 94
Hebei 89
Vienna 89
Amsterdam 88
Tianjin 82
London 81
Abeokuta 80
Biên Hòa 80
Nuremberg 80
Jiaxing 79
The Dalles 79
Phoenix 77
Johannesburg 76
Des Moines 75
Hangzhou 75
Toronto 74
Medford 73
Mülheim 73
Brussels 72
Montreal 72
Orem 71
Hải Dương 69
Zhengzhou 69
Falkenstein 66
Atlanta 64
Jakarta 62
Warsaw 62
Brooklyn 55
Can Tho 55
Olalla 55
Paris 53
Baghdad 51
Bangkok 49
Totale 48.527
Salva come PNG Salva come JPEG
Nome #
Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition in 83 countries 1.877
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 1.644
Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy 592
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 444
Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis 403
Extracorporeal interval support for organ retrieval delivery regional experience with sharing equipe, equipment & expertise to increase conventionally defined as controlled donor pool in time of pandemic 393
Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe 382
Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases 357
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 355
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 333
Infected pancreatic necrosis: outcomes and clinical predictors of mortality. A post hoc analysis of the MANCTRA-1 international study 323
A comprehensive analysis on expected years of life lost due to pancreatic cancer 313
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 303
Monofocal hepatocellular carcinoma: How much does size matter? 302
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 294
Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 Patients 285
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 275
Prognostic criteria for postoperative mortality in 170 patients undergoing major right hepatectomy 272
A new liver transplant priority for patients with hepatocellular carcinoma. 269
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 263
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 259
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 258
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. 256
Global 30-day morbidity and mortality of surgery for perforated peptic ulcer: GRACE study 252
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 251
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 251
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 249
Pattern of macrovascular invasion in hepatocellular carcinoma 246
Anticorpi anti-HLA preformati e Trapianto Combinato Rene-Fegato. Caso clinico. 245
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 245
Surgical therapy for hepatolithiasis: a Western experience. 242
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 241
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 240
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 240
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 235
EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones 235
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 231
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 229
The changing scenario of hepatocellular carcinoma in Italy: an update 227
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 227
GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients 226
Resection line involvement after gastric cancer treatment: handle with care 223
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies. 222
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 222
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 222
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 221
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 218
Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatment 218
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 218
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 217
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 217
Combined liver–dual kidney transplant: Role in expanded donors 216
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 215
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 215
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 214
Coping strategies in intestinal transplantation 214
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 214
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 213
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 213
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 212
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery 210
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 210
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 210
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 210
Abdominal wall defect repair with biological prosthesis in transplanted patients: single center retrospective analysis and review of the literature 209
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 208
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 208
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 207
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 207
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical-Radiomic Model 206
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 206
Implementation of a patient blood management in an Italian City Hospital: is it effective in reducing the use of red blood cells? 205
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study 205
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. 204
Years of Life Lost for Older Patients After Colorectal Cancer Diagnosis 204
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 202
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 201
Prognostic significance of tumor doubling time in mass-forming type cholangiocarcinoma. 201
Metabolic disorders across hepatocellular carcinoma in Italy 201
Combined heart-liver transplantation: A single-center experience 200
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 200
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 198
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin 197
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 197
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 197
Efficacy of MELD score in predicting survival after liver retransplantation. 196
Gastric splenosis mimicking a gastrointestinal stromal tumor: A case report 196
In Reply 196
Combined Liver-Kidney Transplantation With Preformed Anti-HLA Antibodies: A Case Report. 196
A prospective comparative study between celsior and university of Wisconsin preserving solution in liver transplantation from elderly donors 196
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors 194
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape: Bertinoro Workshop, November 2022 194
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 194
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 194
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 193
Assessment of perioperative transfusion requirement for cirrhotic patients undergoing elective hepatectomy 192
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 191
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 191
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 191
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 190
Totale 26.895
Salva come PNG Salva come JPEG
Categoria #
all - tutte 219.400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.400
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.555 0 273 373 523 638 331 163 539 365 370 1.889 1.091
2022/20237.795 724 1.095 419 913 525 590 252 491 1.364 240 735 447
2023/20242.478 192 392 170 269 208 423 148 182 100 169 120 105
2024/202511.909 462 1.521 967 924 1.878 695 863 442 354 789 626 2.388
2025/202630.081 2.084 2.411 2.422 1.894 2.810 3.028 4.077 916 5.375 2.275 1.496 1.293
2026/20272.020 814 1.206 0 0 0 0 0 0 0 0 0 0
Totale 78.934